Stock analysis · Bull Rankings model

OHI analysis

Omega Healthcare Investors, Inc.REIT - Healthcare Facilities. Scored on the same transparent model behind the daily rankings.

OHI
Omega Healthcare Investors, Inc. · REIT - Healthcare Facilities
Yield5.8%A-
Rev+13.2%B+
D/E0.71B+
74.6REIT strength
$46.03$14.7B
1Y Target$51.94Analyst consensus · 18 analysts
5Y Target$76.05Compound horizon
10Y Target$112.82Long-dated conviction
Yield5.8%
A-
Yield 5.8% — strong income · REITs are valued on FFO / AFFO, which our data source doesn't provide — we grade income, growth, and sector-relative leverage instead.
Rev+13.2%
B+
Revenue +13.2% — above sector median, healthy trajectory
D/E0.71
B+
D/E 0.71 — below the Real Estate debt median (≈40th pctile)

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Financial strength · 74.6 / 100
Profitability100.0
Value (P/B)40.6
Income95.3

A peer-relative read for reits on profitability (ROE, depreciation-adjusted), valuation, and covered income — the quality-growth (FCF/ROIC) screen doesn't apply to balance-sheet businesses. Not comparable to the 0–100 quality-growth score shown on other stocks.

Entry · Margin of safety
52-week rangeMid-range
12% off the 12-month high

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
REIT - Healthcare Facilities · market cap $14.7b. 12% off the 52-week high of $52.39. Revenue growing +13%, comfortably above the S&P median. 18 sell-side analysts rate this a Buy with a mean 1-yr target of $51.94 (implying +13% upside).
Moat
Net margin 68% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Dividend payout 95% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 11.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Horizon
1-3 yr $51.94 (18-analyst consensus) — fundamentals + valuation re-rating. 5 yr $76.05 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $112.82 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Not enough history yet — the model records OHI's score after each daily run, and the chart appears once a few days have accumulated.

OHI at a glance

FINANCIAL STRENGTH · REITPROFITABILITY100VALUE41COVERED INCOME9574.6/100 on our peer scale — not the quality-growth score.
PRICE IN ITS 52-WEEK RANGE$46$39.3 LOWHIGH $52.4Trading at the 52nd percentile of its 52-week range ($39.3–$52.4).
ONE-YEAR MOVE VS ITS BETAFLATThis stock+11%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.

Every figure here comes from the same audited fundamentals behind the score. Charts drawn from data the score does not use say so on the card.

Analyst estimate revisions

30-day change+0.5%
90-day change+0.4%
Forward EPS estimate$2.04

Over the last 90 days, what analysts expect OHI to earn is essentially unchanged. The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
43
Position size
$1,979
4.0% of portfolio
Stop price
$34.52
25% below $46.03
$ at risk if stopped
$494.82
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Omega Healthcare Investors, Inc. (OHI): score, valuation & FAQ

Omega Healthcare Investors, Inc. (OHI) is a REIT - Healthcare Facilities company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.

Its strongest graded signals are Yield (A-), Rev (B+) and D/E (B+).

Is OHI a good stock to buy?

Bull Rankings grades OHI on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by Yield (A-), Rev (B+) and D/E (B+). A score is a quantitative screen of Omega Healthcare Investors, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

How does Bull Rankings grade OHI?

As a bank, insurer or REIT, OHI isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on Yield (A-), Rev (B+) and D/E (B+).

Is OHI overvalued or undervalued?

We don't compute a reliable discounted-cash-flow value for OHI — typically because it is not yet consistently profitable or free-cash-flow positive — so its valuation rests on growth and price-to-sales rather than on earnings-based intrinsic value. Judge it on the trajectory of the business, not a single multiple.

What are the main risks of investing in OHI?

Dividend payout 95% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 11.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Healthcare REITs stocks by score

All Real Estate rankings →

Analyze another ticker →